Satoshi Takei

Prof. Satoshi Takei

Department of Pharmaceutical Engineering, Toyama Prefectural University, Imizu, Japan
orcid
Life Science Material Lab., Toyama Prefectural University, ...

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Microelectronic Engineering
Verified
Journal Article
Closed access
Satoshi TakeiSatoshi Takei
Satoshi Takei
AOAkihiro Oshima
Akihiro Oshima
TITakumi Ichikawa
Takumi Ichikawa
ASAtsushi Sekiguchi
Atsushi Sekiguchi
MKMiki Kashiwakura
Miki Kashiwakura
HMHiroshi Miyasaka
Hiroshi Miyasaka

1 November 2007 in Japanese Journal of Applied Physics
Verified
Journal Article
Closed access
Satoshi TakeiSatoshi Takei
Satoshi Takei
TSTetsuya Shinjo
Tetsuya Shinjo
YSYasushi Sakaida
Yasushi Sakaida

23 January 2025 in Gels
Verified
Journal Article
Open access
PDF file
SMSayaka Miura
Sayaka Miura
RYRio Yamagishi
Rio Yamagishi
MAMano Ando
Mano Ando
YHYuna Hachikubo
Yuna Hachikubo
NINor Amirrah Ibrahim
Nor Amirrah Ibrahim
Satoshi TakeiSatoshi Takei
Satoshi Takei
Transdermal drug delivery minimizes pain and provides a controlled, stable release of drugs, but its effectiveness is limited by the skin’s natural barriers. Microneedles overcome this problem, enabling minimally invasive drug delivery. Microneedle patches (MNPs) with 80 µm-tall needles composed of hyaluronic acid (HA) were developed and evaluated for their formability, structural integrity, dissolution rate, skin penetration ability, and drug transmission capacity. The influence of the molecular weight of HA on these properties was also investigated. MNPs made from low-molecular-weight HA (30 kDa–50 kDa) demonstrated 12.5 times superior drug permeability in ex vivo human skin compared to needleless patches (NLPs). Furthermore, in the same test, low-molecular-weight HA MNPs had 1.7 times higher drug permeability than high-molecular-weight HA MNPs, suggesting superior transdermal administration. The molecular weight of HA significantly influenced its solubility and permeability, highlighting the potential effectiveness of MNPs as drug delivery systems. Puncture tests demonstrated a penetration depth of 50–60 µm, indicating minimal nerve irritation in the dermis and effective drug delivery to the superficial dermal layer. These results present a manufacturing technique for MNPs incorporating model drug compounds and highlight their potential as a novel and minimally invasive drug delivery method for the biomedical applications of soft gels.

4 May 2016 in Macromolecular Materials and Engineering
Verified
Journal Article
Closed access
PDF file
Satoshi TakeiSatoshi Takei
Satoshi Takei
SNShinya Nakajima
Shinya Nakajima
KSKigen Sugahara
Kigen Sugahara
MHMakoto Hanabata
Makoto Hanabata
YMYoko Matsumoto
Yoko Matsumoto
ASAtsushi Sekiguchi
Atsushi Sekiguchi

30 October 2014 in Japanese Journal of Applied Physics
Verified
Journal Article
Closed access
Satoshi TakeiSatoshi Takei
Satoshi Takei
AOAkihiro Oshima
Akihiro Oshima
TOTomoko Oyama
Tomoko Oyama
KIKenta Ito
Kenta Ito
KSKigen Sugahara
Kigen Sugahara
MHMakoto Hanabata
Makoto Hanabata

15 April 2016 in Applied Physics Express
Verified
Journal Article
Closed access
PDF file
Satoshi TakeiSatoshi Takei
Satoshi Takei
MHMakoto Hanabata
Makoto Hanabata
This study aimed to expand the resolution limits of epoxy novolac resins that have enhanced etch resistance as one of the desirable resist properties for next-generation devices. Epoxy novolac resins have high etch resistance. However, because epoxy novolac resins are either solid or semisolid at room temperature, and because the use of volatile solvents in resist can be a cause of pattern failure in nanoimprint lithography, epoxy novolac resins have been of limited utility as resist. Excellent sub-70 nm resolution patterning can be achieved by diluting 15 wt % acetone in an ultraviolet nanoimprint lithography using gas-permeable templates.